Terms: = Breast cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
441 results:
1. Discovery of an independent poor-prognosis subtype associated with tertiary lymphoid structures in breast cancer.
Liu R; Huang X; Yang S; Du W; Chen X; Li H
Front Immunol; 2024; 15():1364506. PubMed ID: 38571938
[TBL] [Abstract] [Full Text] [Related]
2. Assessing the relationship between tumor-infiltrating lymphocytes and PD-L1 expression in triple negative breast cancer: Identifying optimal TILs cut-off value for pathologic reporting.
Suwannaphoom K; Soontornsit S; Wiwatwarayos K; Seneetuntigul P; Julimasart P
Ann Diagn Pathol; 2024 Jun; 70():152294. PubMed ID: 38513466
[TBL] [Abstract] [Full Text] [Related]
3. PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC; Chang TC; Wang Y; Guo L; Gao Y; Bikorimana E; Lemoff A; Fang YV; Zhang H; Zhang Y; Ye D; Soria-Bretones I; Servetto A; Lee KM; Luo X; Otto JJ; Akamatsu H; Napolitano F; Mani R; Cescon DW; Xu L; Xie Y; Mendell JT; Hanker AB; Arteaga CL
Nat Commun; 2024 Mar; 15(1):2287. PubMed ID: 38480701
[TBL] [Abstract] [Full Text] [Related]
4. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
[TBL] [Abstract] [Full Text] [Related]
5. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
6. A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER- cells via endoplasmic reticulum stress-induced apoptosis.
Yang T; Li W; Zhou J; Xu M; Huang Z; Ming J; Huang T
Cell Death Dis; 2024 Feb; 15(2):147. PubMed ID: 38360722
[TBL] [Abstract] [Full Text] [Related]
7. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises.
Ahmad J; Ahamad J; Algahtani MS; Garg A; Shahzad N; Ahmad MZ; Imam SS
Expert Opin Drug Deliv; 2024 Feb; 21(2):229-244. PubMed ID: 38344809
[TBL] [Abstract] [Full Text] [Related]
8. Immunotherapy for non-small cell lung cancer.
Kagamu H
Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of Malignant Lymphoma of the Bile Duct Mimicking Cholangiocarcinoma].
Saeki S; Tokumitsu Y; Shindo Y; Matsui H; Nakajima M; Kimura Y; Iida M; Suzuki N; Takeda S; Ioka T; Nagano H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1627-1629. PubMed ID: 38303363
[TBL] [Abstract] [Full Text] [Related]
10. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
11. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
12. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-fus-FSP1 complex.
Wang S; Chen J; Li P; Chen Y
Cell Death Dis; 2023 Nov; 14(11):767. PubMed ID: 38007473
[TBL] [Abstract] [Full Text] [Related]
13. Small-Molecule Endoplasmic Reticulum Stress Inducer Triggers Apoptosis in cancer Cells.
Ingle J; Tirkey A; Pandey S; Basu S
ChemMedChem; 2023 Dec; 18(24):e202300433. PubMed ID: 37964696
[TBL] [Abstract] [Full Text] [Related]
14. Optimization of the Tracking Beam Sequence in Harmonic Motion Imaging.
Liu Y; Saharkhiz N; Hossain MM; Konofagou EE
IEEE Trans Ultrason Ferroelectr Freq Control; 2024 Jan; 71(1):102-116. PubMed ID: 37917522
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
16. Artificial intelligence-assisted ultrasound-guided focused ultrasound therapy: a feasibility study.
Sadeghi-Goughari M; Rajabzadeh H; Han JW; Kwon HJ
Int J Hyperthermia; 2023; 40(1):2260127. PubMed ID: 37748776
[TBL] [Abstract] [Full Text] [Related]
17. UPR-Induced miR-616 Inhibits Human breast cancer Cell Growth and Migration by Targeting c-MYC.
Arabkari V; Sultana A; Barua D; Webber M; Smith T; Gupta A; Gupta S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685841
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes.
Sanuki F; Mikami Y; Nishimura H; Fujita Y; Monobe Y; Nomura T; Taira N; Moriya T
Breast Cancer; 2023 Nov; 30(6):1041-1053. PubMed ID: 37642903
[TBL] [Abstract] [Full Text] [Related]
19. Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer.
Dasgupta A; Saifuddin M; McNabb E; Ho L; Lu L; Vesprini D; Karam I; Soliman H; Chow E; Gandhi S; Trudeau M; Tran W; Curpen B; Stanisz G; Sahgal A; Kolios M; Czarnota GJ
Sci Rep; 2023 Aug; 13(1):13566. PubMed ID: 37604988
[TBL] [Abstract] [Full Text] [Related]
20. Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer.
Wang L; Gong S; Pang L; Zhang S; Zhang X; He W
Sci Rep; 2023 Aug; 13(1):13542. PubMed ID: 37598257
[TBL] [Abstract] [Full Text] [Related]
[Next]